ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
ReNova
|
924 |
286K |
7 |
02/11/24 |
02/11/24 |
ASX - By Stock
|
924
|
286K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Chat GPT Q&A
|
|
ReNova
|
221 |
83K |
17 |
30/10/24 |
30/10/24 |
ASX - By Stock
|
221
|
83K
|
17
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
ReNova
|
2.5K |
848K |
44 |
20/10/24 |
20/10/24 |
ASX - By Stock
|
2.5K
|
848K
|
44
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
ReNova
|
12K |
4.2M |
1 |
04/10/24 |
04/10/24 |
General
|
12K
|
4.2M
|
1
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
ReNova
|
12K |
4.2M |
4 |
03/10/24 |
03/10/24 |
General
|
12K
|
4.2M
|
4
|
|
ASX - By Stock
|
RAC Biotech |
Re:
CEO of Race Oncology posting on a public internet forum
|
|
ReNova
|
302 |
87K |
38 |
27/09/24 |
27/09/24 |
ASX - By Stock
|
302
|
87K
|
38
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
ReNova
|
3.0K |
1.0M |
2 |
23/09/24 |
23/09/24 |
ASX - By Stock
|
3.0K
|
1.0M
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
ReNova
|
3.0K |
1.0M |
9 |
23/09/24 |
23/09/24 |
ASX - By Stock
|
3.0K
|
1.0M
|
9
|
|
ASX - By Stock
|
RAC |
Re:
Ann: HealthInvest 2024 Investor Presentation
|
|
ReNova
|
31 |
10K |
1 |
19/09/24 |
19/09/24 |
ASX - By Stock
|
31
|
10K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: HealthInvest 2024 Investor Presentation
|
|
ReNova
|
31 |
10K |
1 |
19/09/24 |
19/09/24 |
ASX - By Stock
|
31
|
10K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
ReNova
|
307 |
97K |
0 |
06/09/24 |
06/09/24 |
ASX - By Stock
|
307
|
97K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
ReNova
|
854 |
316K |
26 |
05/09/24 |
05/09/24 |
ASX - By Stock
|
854
|
316K
|
26
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
ReNova
|
854 |
316K |
98 |
05/09/24 |
05/09/24 |
ASX - By Stock
|
854
|
316K
|
98
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
ReNova
|
2.5K |
848K |
6 |
28/08/24 |
28/08/24 |
ASX - By Stock
|
2.5K
|
848K
|
6
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
ReNova
|
12K |
4.2M |
5 |
25/08/24 |
25/08/24 |
General
|
12K
|
4.2M
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race to Present at TechKnow July Conference
|
|
ReNova
|
132 |
34K |
17 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
132
|
34K
|
17
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race to Present at TechKnow July Conference
|
|
ReNova
|
132 |
34K |
33 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
132
|
34K
|
33
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
ReNova
|
146 |
46K |
18 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
146
|
46K
|
18
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
ReNova
|
146 |
46K |
1 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
146
|
46K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Appoints George Clinical for Phase 1 Trial of RC220
|
|
ReNova
|
146 |
46K |
11 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
146
|
46K
|
11
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
ReNova
|
391 |
86K |
24 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
391
|
86K
|
24
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
ReNova
|
12K |
4.2M |
10 |
06/07/24 |
06/07/24 |
General
|
12K
|
4.2M
|
10
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Distinguished Oncologist Daniel Von Hoff Joins as Consultant
|
|
ReNova
|
168 |
49K |
22 |
05/07/24 |
05/07/24 |
ASX - By Stock
|
168
|
49K
|
22
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Distinguished Oncologist Daniel Von Hoff Joins as Consultant
|
|
ReNova
|
168 |
49K |
6 |
05/07/24 |
05/07/24 |
ASX - By Stock
|
168
|
49K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Distinguished Oncologist Daniel Von Hoff Joins as Consultant
|
|
ReNova
|
168 |
49K |
18 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
168
|
49K
|
18
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RC220 GLP Non-clinical Toxicology Program Successful
|
|
ReNova
|
80 |
26K |
4 |
27/06/24 |
27/06/24 |
ASX - By Stock
|
80
|
26K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
ReNova
|
2.3K |
792K |
7 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
2.3K
|
792K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
ReNova
|
2.3K |
792K |
7 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
2.3K
|
792K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
ReNova
|
2.3K |
792K |
38 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
2.3K
|
792K
|
38
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
ReNova
|
2.5K |
848K |
7 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
2.5K
|
848K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
ReNova
|
2.5K |
848K |
6 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
2.5K
|
848K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Application for quotation of securities - RAC
|
|
ReNova
|
35 |
11K |
7 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
35
|
11K
|
7
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
ReNova
|
12K |
4.2M |
8 |
27/05/24 |
27/05/24 |
General
|
12K
|
4.2M
|
8
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
ReNova
|
924 |
286K |
3 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
924
|
286K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Notification of cessation of securities - RAC
|
|
ReNova
|
64 |
21K |
24 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
64
|
21K
|
24
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race releases complete cardio-protection data & video
|
|
ReNova
|
236 |
92K |
11 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
236
|
92K
|
11
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
ReNova
|
2.3K |
792K |
4 |
08/02/24 |
08/02/24 |
ASX - By Stock
|
2.3K
|
792K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
ReNova
|
924 |
286K |
9 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
924
|
286K
|
9
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
ReNova
|
22K |
8.1M |
1 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
22K
|
8.1M
|
1
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
ReNova
|
22K |
8.1M |
3 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
22K
|
8.1M
|
3
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
ReNova
|
12K |
4.2M |
18 |
25/01/24 |
25/01/24 |
General
|
12K
|
4.2M
|
18
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
ReNova
|
12K |
4.2M |
38 |
11/01/24 |
11/01/24 |
General
|
12K
|
4.2M
|
38
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
ReNova
|
924 |
286K |
14 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
924
|
286K
|
14
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
ReNova
|
924 |
286K |
8 |
01/01/24 |
01/01/24 |
ASX - By Stock
|
924
|
286K
|
8
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
ReNova
|
508 |
133K |
5 |
05/12/23 |
05/12/23 |
ASX - By Stock
|
508
|
133K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
ReNova
|
508 |
133K |
6 |
05/12/23 |
05/12/23 |
ASX - By Stock
|
508
|
133K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
ReNova
|
508 |
133K |
2 |
04/12/23 |
04/12/23 |
ASX - By Stock
|
508
|
133K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
ReNova
|
508 |
133K |
3 |
04/12/23 |
04/12/23 |
ASX - By Stock
|
508
|
133K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Zantrene highly effective in EMD AML Mouse Model
|
|
ReNova
|
115 |
44K |
5 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
115
|
44K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Zantrene highly effective in EMD AML Mouse Model
|
|
ReNova
|
115 |
44K |
38 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
115
|
44K
|
38
|
|